600 related articles for article (PubMed ID: 8403814)
21. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
22. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
Meyrier A
J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
[TBL] [Abstract][Full Text] [Related]
23. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
24. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS; Sergeeva TV
Ter Arkh; 2002; 74(6):31-3. PubMed ID: 12136479
[TBL] [Abstract][Full Text] [Related]
25. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
Belovezhdov N
Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
[TBL] [Abstract][Full Text] [Related]
26. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
Gulati S; Sharma AP; Sharma RK; Gupta A; Gupta RK
Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
[TBL] [Abstract][Full Text] [Related]
27. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
29. [Membranous kidney diseases in adults].
Sobarzo Toro M; Vilches A
Medicina (B Aires); 2004; 64(1):59-65. PubMed ID: 15034960
[TBL] [Abstract][Full Text] [Related]
30. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P; Schneider A; Grabensee B; Plum J
Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine treatment of glomerular diseases.
Klein M; Radhakrishnan J; Appel G
Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of primary chronic glomerulonephritis].
Risler T; Braun N; Erley CM
Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
[TBL] [Abstract][Full Text] [Related]
34. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Yoshio T; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
[TBL] [Abstract][Full Text] [Related]
35. Pefloxacin as first-line treatment in nephrotic syndrome.
Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
[No Abstract] [Full Text] [Related]
36. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
37. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
38. Partial remission of resistant nephrotic syndrome after oral galactose therapy.
Kopač M; Meglič A; Rus RR
Ther Apher Dial; 2011 Jun; 15(3):269-72. PubMed ID: 21624074
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
40. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
